Reported Consolidated quarterly numbers for Sun Pharma Advanced Research Company are:Net Sales at Rs 27.19 crore in March 2025 up 64.19% from Rs. 16.56 crore in March 2024.
Story continues below Advertisement
Quarterly Net Loss at Rs. 59.77 crore in March 2025 up 43.5% from Rs. 105.79 crore in March 2024.
EBITDA stands negative at Rs. 53.18 crore in March 2025 up 47.57% from Rs. 101.43 crore in March 2024.
Sun Pharma Adv shares closed at 167.03 on May 16, 2025 (NSE) and has given -14.77% returns over the last 6 months and -22.60% over the last 12 months.
| Sun Pharma Advanced Research Company | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'25 | Dec'24 | Mar'24 | | Net Sales/Income from operations | 27.19 | 14.91 | 16.56 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 27.19 | 14.91 | 16.56 | | EXPENDITURE | | Consumption of Raw Materials | 5.70 | 4.58 | 7.46 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -- | -- | -- | | Power & Fuel | -- | -- | -- | | Employees Cost | 29.85 | 30.99 | 50.03 | | Depreciation | 2.95 | 3.14 | 3.07 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 44.82 | 53.03 | 64.90 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -56.13 | -76.83 | -108.90 | | Other Income | -- | 0.19 | 4.40 | | P/L Before Int., Excpt. Items & Tax | -56.13 | -76.64 | -104.50 | | Interest | 4.54 | 2.80 | 0.91 | | P/L Before Exceptional Items & Tax | -60.67 | -79.44 | -105.41 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -60.67 | -79.44 | -105.41 | | Tax | -0.90 | 0.07 | 0.38 | | P/L After Tax from Ordinary Activities | -59.77 | -79.51 | -105.79 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -59.77 | -79.51 | -105.79 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -59.77 | -79.51 | -105.79 | | Equity Share Capital | 32.45 | 32.45 | 32.45 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.84 | -2.45 | -3.26 | | Diluted EPS | -1.84 | -2.45 | -3.26 | | EPS After Extra Ordinary | | Basic EPS | -1.84 | -2.45 | -3.26 | | Diluted EPS | -1.84 | -2.45 | -3.26 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
